Meridian Bioscience cuts dividend by 37.5%

Meridian Bioscience (VIVO) will lower its quarterly dividend from $0.20 to $0.125 per share.

Based on current business trends, the Board of Directors reduced the annual indicated dividend rate from $0.80 per share to $0.50, and declared the regular quarterly cash dividend of $0.125 per share for the first quarter ended December 31, 2016. The dividend is of record February 6, 2017 and payable February 16, 2017. Guided by the Company's policy of setting a payout ratio of between 75% and 85% of each fiscal year's expected net earnings, the actual declaration and amount of dividends will be determined by the Board of Directors in its discretion based upon its evaluation of earnings, cash flow requirements and future business developments, including any acquisitions.

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes diagnostic test kits, rare reagents, specialty biologicals and components.

Recent headlines